nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—CYP1A2—Carmustine—brain cancer	0.136	0.276	CbGbCtD
Clomifene—CYP3A4—Temozolomide—brain cancer	0.103	0.209	CbGbCtD
Clomifene—CYP3A4—Lomustine—brain cancer	0.0872	0.177	CbGbCtD
Clomifene—CYP2E1—Etoposide—brain cancer	0.0696	0.142	CbGbCtD
Clomifene—Brain abscess—Carmustine—brain cancer	0.043	0.137	CcSEcCtD
Clomifene—Astrocytoma—Temozolomide—brain cancer	0.0415	0.132	CcSEcCtD
Clomifene—CYP1A2—Etoposide—brain cancer	0.0402	0.0819	CbGbCtD
Clomifene—ABCB1—Etoposide—brain cancer	0.0352	0.0716	CbGbCtD
Clomifene—CYP3A4—Etoposide—brain cancer	0.0211	0.0429	CbGbCtD
Clomifene—Hydrocephalus—Carmustine—brain cancer	0.0158	0.0502	CcSEcCtD
Clomifene—Retinal haemorrhage—Procarbazine—brain cancer	0.00729	0.0232	CcSEcCtD
Clomifene—Leukaemia—Hydroxyurea—brain cancer	0.00683	0.0218	CcSEcCtD
Clomifene—Blindness—Lomustine—brain cancer	0.00676	0.0215	CcSEcCtD
Clomifene—Ascites—Procarbazine—brain cancer	0.00523	0.0167	CcSEcCtD
Clomifene—Retinal haemorrhage—Carmustine—brain cancer	0.00456	0.0145	CcSEcCtD
Clomifene—Vasospasm—Carmustine—brain cancer	0.00435	0.0139	CcSEcCtD
Clomifene—Optic neuritis—Procarbazine—brain cancer	0.00386	0.0123	CcSEcCtD
Clomifene—Phlebitis—Carboplatin—brain cancer	0.0036	0.0115	CcSEcCtD
Clomifene—Neoplasm—Lomustine—brain cancer	0.00338	0.0108	CcSEcCtD
Clomifene—Thrombosis—Procarbazine—brain cancer	0.00336	0.0107	CcSEcCtD
Clomifene—Ospemifene—CYP2C9—brain cancer	0.00319	0.482	CrCbGaD
Clomifene—Disorder sight—Temozolomide—brain cancer	0.00302	0.00961	CcSEcCtD
Clomifene—Visual disturbance—Lomustine—brain cancer	0.00287	0.00913	CcSEcCtD
Clomifene—EBP—endocrine gland—brain cancer	0.00254	0.0557	CbGeAlD
Clomifene—Ascites—Etoposide—brain cancer	0.00253	0.00806	CcSEcCtD
Clomifene—Transaminases increased—Carmustine—brain cancer	0.00244	0.00779	CcSEcCtD
Clomifene—Visual acuity reduced—Temozolomide—brain cancer	0.00242	0.0077	CcSEcCtD
Clomifene—Embolism—Temozolomide—brain cancer	0.00224	0.00713	CcSEcCtD
Clomifene—Photophobia—Procarbazine—brain cancer	0.00223	0.00711	CcSEcCtD
Clomifene—Cyst—Carmustine—brain cancer	0.00222	0.00709	CcSEcCtD
Clomifene—Tenderness—Hydroxyurea—brain cancer	0.00211	0.00672	CcSEcCtD
Clomifene—Thrombosis—Carmustine—brain cancer	0.0021	0.00669	CcSEcCtD
Clomifene—Renal failure—Lomustine—brain cancer	0.00206	0.00656	CcSEcCtD
Clomifene—Myopathy—Temozolomide—brain cancer	0.00205	0.00653	CcSEcCtD
Clomifene—ESR1—blood vessel—brain cancer	0.00198	0.0434	CbGeAlD
Clomifene—Scotoma—Carmustine—brain cancer	0.00196	0.00624	CcSEcCtD
Clomifene—Menorrhagia—Temozolomide—brain cancer	0.00194	0.00618	CcSEcCtD
Clomifene—Deafness—Procarbazine—brain cancer	0.00193	0.00614	CcSEcCtD
Clomifene—Cholestasis—Temozolomide—brain cancer	0.00189	0.00603	CcSEcCtD
Clomifene—Scotoma—Temozolomide—brain cancer	0.00189	0.00603	CcSEcCtD
Clomifene—ESR1—hindbrain—brain cancer	0.00189	0.0414	CbGeAlD
Clomifene—Optic neuritis—Etoposide—brain cancer	0.00187	0.00595	CcSEcCtD
Clomifene—Visual impairment—Lomustine—brain cancer	0.00181	0.00577	CcSEcCtD
Clomifene—Diplopia—Procarbazine—brain cancer	0.00172	0.0055	CcSEcCtD
Clomifene—Neoplasm—Hydroxyurea—brain cancer	0.00166	0.0053	CcSEcCtD
Clomifene—Alopecia—Lomustine—brain cancer	0.00166	0.00529	CcSEcCtD
Clomifene—Leukocytosis—Carmustine—brain cancer	0.00158	0.00504	CcSEcCtD
Clomifene—Pulmonary embolism—Carmustine—brain cancer	0.00149	0.00474	CcSEcCtD
Clomifene—Pancreatitis—Procarbazine—brain cancer	0.00146	0.00466	CcSEcCtD
Clomifene—Pulmonary embolism—Temozolomide—brain cancer	0.00144	0.00458	CcSEcCtD
Clomifene—CYP11A1—gonad—brain cancer	0.00142	0.0311	CbGeAlD
Clomifene—Pollakiuria—Procarbazine—brain cancer	0.00138	0.00439	CcSEcCtD
Clomifene—Neoplasm—Carmustine—brain cancer	0.00134	0.00428	CcSEcCtD
Clomifene—CYP11A1—medulla oblongata—brain cancer	0.00133	0.0293	CbGeAlD
Clomifene—Tamoxifen—ESR2—brain cancer	0.00132	0.2	CrCbGaD
Clomifene—Pain—Carboplatin—brain cancer	0.00131	0.00416	CcSEcCtD
Clomifene—Neoplasm—Temozolomide—brain cancer	0.0013	0.00414	CcSEcCtD
Clomifene—Jaundice—Procarbazine—brain cancer	0.0013	0.00413	CcSEcCtD
Clomifene—Mental disability—Carmustine—brain cancer	0.00129	0.00411	CcSEcCtD
Clomifene—Phlebitis—Carmustine—brain cancer	0.00125	0.00399	CcSEcCtD
Clomifene—Mental disability—Temozolomide—brain cancer	0.00125	0.00397	CcSEcCtD
Clomifene—Thrombophlebitis—Carmustine—brain cancer	0.00125	0.00397	CcSEcCtD
Clomifene—Body temperature increased—Carboplatin—brain cancer	0.00121	0.00384	CcSEcCtD
Clomifene—Thrombophlebitis—Temozolomide—brain cancer	0.0012	0.00384	CcSEcCtD
Clomifene—Eye pain—Carmustine—brain cancer	0.0012	0.00381	CcSEcCtD
Clomifene—Deafness—Temozolomide—brain cancer	0.00117	0.00371	CcSEcCtD
Clomifene—Eye pain—Temozolomide—brain cancer	0.00116	0.00368	CcSEcCtD
Clomifene—Pancreatitis—Hydroxyurea—brain cancer	0.00113	0.0036	CcSEcCtD
Clomifene—Hot flush—Temozolomide—brain cancer	0.00111	0.00355	CcSEcCtD
Clomifene—Flushing—Procarbazine—brain cancer	0.00111	0.00353	CcSEcCtD
Clomifene—Menopausal symptoms—Temozolomide—brain cancer	0.00111	0.00352	CcSEcCtD
Clomifene—SIGMAR1—telencephalon—brain cancer	0.00108	0.0238	CbGeAlD
Clomifene—ESR1—brainstem—brain cancer	0.00108	0.0237	CbGeAlD
Clomifene—Diplopia—Carmustine—brain cancer	0.00108	0.00344	CcSEcCtD
Clomifene—CYP11A1—endocrine gland—brain cancer	0.00107	0.0235	CbGeAlD
Clomifene—Arrhythmia—Procarbazine—brain cancer	0.00107	0.0034	CcSEcCtD
Clomifene—Diphenhydramine—CYP2C9—brain cancer	0.00107	0.161	CrCbGaD
Clomifene—CYP11A1—head—brain cancer	0.00106	0.0232	CbGeAlD
Clomifene—Body temperature increased—Lomustine—brain cancer	0.00106	0.00336	CcSEcCtD
Clomifene—Alopecia—Procarbazine—brain cancer	0.00105	0.00336	CcSEcCtD
Clomifene—Weight increased—Hydroxyurea—brain cancer	0.00105	0.00335	CcSEcCtD
Clomifene—Diplopia—Temozolomide—brain cancer	0.00104	0.00332	CcSEcCtD
Clomifene—Tamoxifen—CYP2C9—brain cancer	0.00104	0.157	CrCbGaD
Clomifene—Affect lability—Temozolomide—brain cancer	0.00103	0.00327	CcSEcCtD
Clomifene—Tension—Procarbazine—brain cancer	0.00102	0.00325	CcSEcCtD
Clomifene—Nervousness—Procarbazine—brain cancer	0.00101	0.00321	CcSEcCtD
Clomifene—Mood swings—Temozolomide—brain cancer	0.000988	0.00315	CcSEcCtD
Clomifene—Phlebitis—Etoposide—brain cancer	0.000969	0.00309	CcSEcCtD
Clomifene—CYP11A1—central nervous system—brain cancer	0.000965	0.0212	CbGeAlD
Clomifene—ESR1—telencephalon—brain cancer	0.000959	0.0211	CbGeAlD
Clomifene—Syncope—Procarbazine—brain cancer	0.000932	0.00297	CcSEcCtD
Clomifene—CYP19A1—gonad—brain cancer	0.000921	0.0202	CbGeAlD
Clomifene—Loss of consciousness—Procarbazine—brain cancer	0.000913	0.00291	CcSEcCtD
Clomifene—Abdominal distension—Temozolomide—brain cancer	0.000907	0.00289	CcSEcCtD
Clomifene—Convulsion—Procarbazine—brain cancer	0.0009	0.00287	CcSEcCtD
Clomifene—Hypertension—Procarbazine—brain cancer	0.000897	0.00286	CcSEcCtD
Clomifene—Arthralgia—Procarbazine—brain cancer	0.000884	0.00282	CcSEcCtD
Clomifene—Myalgia—Procarbazine—brain cancer	0.000884	0.00282	CcSEcCtD
Clomifene—SIGMAR1—pituitary gland—brain cancer	0.000883	0.0194	CbGeAlD
Clomifene—Anxiety—Procarbazine—brain cancer	0.000881	0.00281	CcSEcCtD
Clomifene—KCNH2—telencephalon—brain cancer	0.000863	0.019	CbGeAlD
Clomifene—SIGMAR1—medulla oblongata—brain cancer	0.000852	0.0187	CbGeAlD
Clomifene—Vomiting—Lomustine—brain cancer	0.000849	0.00271	CcSEcCtD
Clomifene—Oedema—Procarbazine—brain cancer	0.000848	0.0027	CcSEcCtD
Clomifene—Shock—Procarbazine—brain cancer	0.000834	0.00266	CcSEcCtD
Clomifene—Pollakiuria—Temozolomide—brain cancer	0.000833	0.00265	CcSEcCtD
Clomifene—Tachycardia—Procarbazine—brain cancer	0.000827	0.00264	CcSEcCtD
Clomifene—Weight increased—Temozolomide—brain cancer	0.00082	0.00261	CcSEcCtD
Clomifene—Renal failure—Carmustine—brain cancer	0.000817	0.0026	CcSEcCtD
Clomifene—Alopecia—Hydroxyurea—brain cancer	0.000816	0.0026	CcSEcCtD
Clomifene—Erythema—Hydroxyurea—brain cancer	0.000804	0.00256	CcSEcCtD
Clomifene—ESR1—gonad—brain cancer	0.0008	0.0176	CbGeAlD
Clomifene—Nausea—Lomustine—brain cancer	0.000793	0.00253	CcSEcCtD
Clomifene—CYP2A6—cerebellum—brain cancer	0.000782	0.0172	CbGeAlD
Clomifene—ESR1—pituitary gland—brain cancer	0.000781	0.0171	CbGeAlD
Clomifene—ABCB1—blood vessel—brain cancer	0.000781	0.0171	CbGeAlD
Clomifene—SIGMAR1—midbrain—brain cancer	0.000779	0.0171	CbGeAlD
Clomifene—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000772	0.00246	CcSEcCtD
Clomifene—Insomnia—Procarbazine—brain cancer	0.000767	0.00244	CcSEcCtD
Clomifene—CYP11A1—brain—brain cancer	0.000766	0.0168	CbGeAlD
Clomifene—Paraesthesia—Procarbazine—brain cancer	0.000761	0.00243	CcSEcCtD
Clomifene—SIGMAR1—spinal cord—brain cancer	0.00076	0.0167	CbGeAlD
Clomifene—Fatigue—Procarbazine—brain cancer	0.000731	0.00233	CcSEcCtD
Clomifene—Constipation—Procarbazine—brain cancer	0.000725	0.00231	CcSEcCtD
Clomifene—Pain—Procarbazine—brain cancer	0.000725	0.00231	CcSEcCtD
Clomifene—Hepatitis—Temozolomide—brain cancer	0.000721	0.0023	CcSEcCtD
Clomifene—Visual impairment—Carmustine—brain cancer	0.000719	0.00229	CcSEcCtD
Clomifene—KCNH2—pituitary gland—brain cancer	0.000703	0.0154	CbGeAlD
Clomifene—Convulsion—Hydroxyurea—brain cancer	0.000697	0.00222	CcSEcCtD
Clomifene—CYP19A1—endocrine gland—brain cancer	0.000696	0.0153	CbGeAlD
Clomifene—Visual impairment—Temozolomide—brain cancer	0.000695	0.00222	CcSEcCtD
Clomifene—Flushing—Carmustine—brain cancer	0.000693	0.00221	CcSEcCtD
Clomifene—CYP19A1—head—brain cancer	0.000687	0.0151	CbGeAlD
Clomifene—Erythema multiforme—Temozolomide—brain cancer	0.000682	0.00217	CcSEcCtD
Clomifene—KCNH2—medulla oblongata—brain cancer	0.000678	0.0149	CbGeAlD
Clomifene—Urticaria—Procarbazine—brain cancer	0.000673	0.00215	CcSEcCtD
Clomifene—Tinnitus—Temozolomide—brain cancer	0.000673	0.00214	CcSEcCtD
Clomifene—Body temperature increased—Procarbazine—brain cancer	0.00067	0.00214	CcSEcCtD
Clomifene—Flushing—Temozolomide—brain cancer	0.00067	0.00213	CcSEcCtD
Clomifene—Arrhythmia—Carmustine—brain cancer	0.000667	0.00212	CcSEcCtD
Clomifene—CYP2E1—telencephalon—brain cancer	0.000665	0.0146	CbGeAlD
Clomifene—Alopecia—Carmustine—brain cancer	0.00066	0.0021	CcSEcCtD
Clomifene—Oedema—Hydroxyurea—brain cancer	0.000656	0.00209	CcSEcCtD
Clomifene—Erythema—Carmustine—brain cancer	0.00065	0.00207	CcSEcCtD
Clomifene—Alopecia—Temozolomide—brain cancer	0.000638	0.00203	CcSEcCtD
Clomifene—CYP2A6—brain—brain cancer	0.000635	0.0139	CbGeAlD
Clomifene—Renal failure—Etoposide—brain cancer	0.000632	0.00201	CcSEcCtD
Clomifene—CYP19A1—Biological oxidations—CYP2C9—brain cancer	0.000632	0.00444	CbGpPWpGaD
Clomifene—Back pain—Carmustine—brain cancer	0.000629	0.002	CcSEcCtD
Clomifene—Erythema—Temozolomide—brain cancer	0.000628	0.002	CcSEcCtD
Clomifene—CYP19A1—central nervous system—brain cancer	0.000627	0.0138	CbGeAlD
Clomifene—Jaundice—Etoposide—brain cancer	0.000627	0.002	CcSEcCtD
Clomifene—Hypersensitivity—Procarbazine—brain cancer	0.000625	0.00199	CcSEcCtD
Clomifene—CYP19A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000623	0.00438	CbGpPWpGaD
Clomifene—KCNH2—midbrain—brain cancer	0.00062	0.0136	CbGeAlD
Clomifene—EBP—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000619	0.00435	CbGpPWpGaD
Clomifene—Vision blurred—Carmustine—brain cancer	0.000612	0.00195	CcSEcCtD
Clomifene—Asthenia—Procarbazine—brain cancer	0.000608	0.00194	CcSEcCtD
Clomifene—Back pain—Temozolomide—brain cancer	0.000607	0.00194	CcSEcCtD
Clomifene—KCNH2—spinal cord—brain cancer	0.000605	0.0133	CbGeAlD
Clomifene—ESR1—endocrine gland—brain cancer	0.000605	0.0133	CbGeAlD
Clomifene—SIGMAR1—cerebellum—brain cancer	0.000603	0.0132	CbGeAlD
Clomifene—Pruritus—Procarbazine—brain cancer	0.0006	0.00191	CcSEcCtD
Clomifene—ESR1—head—brain cancer	0.000597	0.0131	CbGeAlD
Clomifene—Vision blurred—Temozolomide—brain cancer	0.000592	0.00189	CcSEcCtD
Clomifene—Dyspnoea—Hydroxyurea—brain cancer	0.000585	0.00186	CcSEcCtD
Clomifene—Diarrhoea—Procarbazine—brain cancer	0.00058	0.00185	CcSEcCtD
Clomifene—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—brain cancer	0.000577	0.00405	CbGpPWpGaD
Clomifene—Fatigue—Hydroxyurea—brain cancer	0.000566	0.0018	CcSEcCtD
Clomifene—Vertigo—Temozolomide—brain cancer	0.000564	0.0018	CcSEcCtD
Clomifene—Convulsion—Carmustine—brain cancer	0.000563	0.00179	CcSEcCtD
Clomifene—Hypertension—Carmustine—brain cancer	0.000561	0.00179	CcSEcCtD
Clomifene—Constipation—Hydroxyurea—brain cancer	0.000561	0.00179	CcSEcCtD
Clomifene—Pain—Hydroxyurea—brain cancer	0.000561	0.00179	CcSEcCtD
Clomifene—Dizziness—Procarbazine—brain cancer	0.000561	0.00179	CcSEcCtD
Clomifene—Palpitations—Temozolomide—brain cancer	0.000555	0.00177	CcSEcCtD
Clomifene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000555	0.0039	CbGpPWpGaD
Clomifene—Chest pain—Carmustine—brain cancer	0.000553	0.00176	CcSEcCtD
Clomifene—Myalgia—Carmustine—brain cancer	0.000553	0.00176	CcSEcCtD
Clomifene—Anxiety—Carmustine—brain cancer	0.000551	0.00176	CcSEcCtD
Clomifene—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000548	0.00385	CbGpPWpGaD
Clomifene—Erythema multiforme—Etoposide—brain cancer	0.000546	0.00174	CcSEcCtD
Clomifene—ESR1—central nervous system—brain cancer	0.000545	0.012	CbGeAlD
Clomifene—KCNH2—endocrine gland—brain cancer	0.000545	0.012	CbGeAlD
Clomifene—Convulsion—Temozolomide—brain cancer	0.000544	0.00173	CcSEcCtD
Clomifene—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000543	0.00381	CbGpPWpGaD
Clomifene—Hypertension—Temozolomide—brain cancer	0.000542	0.00173	CcSEcCtD
Clomifene—Vomiting—Procarbazine—brain cancer	0.000539	0.00172	CcSEcCtD
Clomifene—KCNH2—head—brain cancer	0.000538	0.0118	CbGeAlD
Clomifene—Flushing—Etoposide—brain cancer	0.000536	0.00171	CcSEcCtD
Clomifene—Arthralgia—Temozolomide—brain cancer	0.000535	0.0017	CcSEcCtD
Clomifene—Myalgia—Temozolomide—brain cancer	0.000535	0.0017	CcSEcCtD
Clomifene—Rash—Procarbazine—brain cancer	0.000535	0.0017	CcSEcCtD
Clomifene—Dermatitis—Procarbazine—brain cancer	0.000534	0.0017	CcSEcCtD
Clomifene—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000533	0.00374	CbGpPWpGaD
Clomifene—Anxiety—Temozolomide—brain cancer	0.000533	0.0017	CcSEcCtD
Clomifene—ESR1—cerebellum—brain cancer	0.000533	0.0117	CbGeAlD
Clomifene—Headache—Procarbazine—brain cancer	0.000531	0.00169	CcSEcCtD
Clomifene—Oedema—Carmustine—brain cancer	0.00053	0.00169	CcSEcCtD
Clomifene—CYP2E1—medulla oblongata—brain cancer	0.000522	0.0115	CbGeAlD
Clomifene—Body temperature increased—Hydroxyurea—brain cancer	0.000519	0.00165	CcSEcCtD
Clomifene—Tachycardia—Carmustine—brain cancer	0.000518	0.00165	CcSEcCtD
Clomifene—Oedema—Temozolomide—brain cancer	0.000513	0.00163	CcSEcCtD
Clomifene—Alopecia—Etoposide—brain cancer	0.00051	0.00163	CcSEcCtD
Clomifene—Nausea—Procarbazine—brain cancer	0.000504	0.0016	CcSEcCtD
Clomifene—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000503	0.00353	CbGpPWpGaD
Clomifene—CYP19A1—brain—brain cancer	0.000498	0.0109	CbGeAlD
Clomifene—ESR1—FOXM1 transcription factor network—CDK4—brain cancer	0.000492	0.00346	CbGpPWpGaD
Clomifene—KCNH2—central nervous system—brain cancer	0.000491	0.0108	CbGeAlD
Clomifene—SIGMAR1—brain—brain cancer	0.00049	0.0107	CbGeAlD
Clomifene—Back pain—Etoposide—brain cancer	0.000486	0.00155	CcSEcCtD
Clomifene—Hypersensitivity—Hydroxyurea—brain cancer	0.000483	0.00154	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Carmustine—brain cancer	0.000483	0.00154	CcSEcCtD
Clomifene—Insomnia—Carmustine—brain cancer	0.00048	0.00153	CcSEcCtD
Clomifene—KCNH2—cerebellum—brain cancer	0.00048	0.0105	CbGeAlD
Clomifene—ESR1—ATF-2 transcription factor network—HES1—brain cancer	0.000478	0.00336	CbGpPWpGaD
Clomifene—Paraesthesia—Carmustine—brain cancer	0.000476	0.00152	CcSEcCtD
Clomifene—Dyspnoea—Carmustine—brain cancer	0.000473	0.00151	CcSEcCtD
Clomifene—Asthenia—Hydroxyurea—brain cancer	0.000471	0.0015	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000467	0.00149	CcSEcCtD
Clomifene—CYP1A2—endocrine gland—brain cancer	0.000466	0.0102	CbGeAlD
Clomifene—CYP2E1—spinal cord—brain cancer	0.000466	0.0102	CbGeAlD
Clomifene—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000464	0.00326	CbGpPWpGaD
Clomifene—Insomnia—Temozolomide—brain cancer	0.000464	0.00148	CcSEcCtD
Clomifene—Paraesthesia—Temozolomide—brain cancer	0.00046	0.00147	CcSEcCtD
Clomifene—CYP1A1—endocrine gland—brain cancer	0.00046	0.0101	CbGeAlD
Clomifene—Dyspnoea—Temozolomide—brain cancer	0.000457	0.00146	CcSEcCtD
Clomifene—ESR1—Signaling by ERBB4—GFAP—brain cancer	0.000457	0.00321	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—PDGFRA—brain cancer	0.000455	0.0032	CbGpPWpGaD
Clomifene—CYP1A1—head—brain cancer	0.000454	0.00997	CbGeAlD
Clomifene—Constipation—Carmustine—brain cancer	0.000454	0.00145	CcSEcCtD
Clomifene—Pain—Carmustine—brain cancer	0.000454	0.00145	CcSEcCtD
Clomifene—Vertigo—Etoposide—brain cancer	0.000452	0.00144	CcSEcCtD
Clomifene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00045	0.00316	CbGpPWpGaD
Clomifene—Diarrhoea—Hydroxyurea—brain cancer	0.000449	0.00143	CcSEcCtD
Clomifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000448	0.00314	CbGpPWpGaD
Clomifene—Fatigue—Temozolomide—brain cancer	0.000442	0.00141	CcSEcCtD
Clomifene—Loss of consciousness—Etoposide—brain cancer	0.000442	0.00141	CcSEcCtD
Clomifene—KCNH2—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000439	0.00308	CbGpPWpGaD
Clomifene—Pain—Temozolomide—brain cancer	0.000438	0.0014	CcSEcCtD
Clomifene—Constipation—Temozolomide—brain cancer	0.000438	0.0014	CcSEcCtD
Clomifene—Convulsion—Etoposide—brain cancer	0.000435	0.00139	CcSEcCtD
Clomifene—Hypertension—Etoposide—brain cancer	0.000434	0.00138	CcSEcCtD
Clomifene—Dizziness—Hydroxyurea—brain cancer	0.000434	0.00138	CcSEcCtD
Clomifene—ESR1—brain—brain cancer	0.000433	0.0095	CbGeAlD
Clomifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000428	0.00301	CbGpPWpGaD
Clomifene—Chest pain—Etoposide—brain cancer	0.000428	0.00136	CcSEcCtD
Clomifene—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000423	0.00297	CbGpPWpGaD
Clomifene—CYP2E1—endocrine gland—brain cancer	0.000419	0.00921	CbGeAlD
Clomifene—Body temperature increased—Carmustine—brain cancer	0.000419	0.00134	CcSEcCtD
Clomifene—Vomiting—Hydroxyurea—brain cancer	0.000417	0.00133	CcSEcCtD
Clomifene—CYP1A1—central nervous system—brain cancer	0.000414	0.0091	CbGeAlD
Clomifene—CYP2E1—head—brain cancer	0.000414	0.00909	CbGeAlD
Clomifene—Rash—Hydroxyurea—brain cancer	0.000414	0.00132	CcSEcCtD
Clomifene—Dermatitis—Hydroxyurea—brain cancer	0.000413	0.00132	CcSEcCtD
Clomifene—Headache—Hydroxyurea—brain cancer	0.000411	0.00131	CcSEcCtD
Clomifene—Urticaria—Temozolomide—brain cancer	0.000407	0.0013	CcSEcCtD
Clomifene—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—brain cancer	0.000407	0.00285	CbGpPWpGaD
Clomifene—Body temperature increased—Temozolomide—brain cancer	0.000405	0.00129	CcSEcCtD
Clomifene—Tachycardia—Etoposide—brain cancer	0.0004	0.00128	CcSEcCtD
Clomifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000399	0.0028	CbGpPWpGaD
Clomifene—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000398	0.00279	CbGpPWpGaD
Clomifene—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000392	0.00275	CbGpPWpGaD
Clomifene—Hypersensitivity—Carmustine—brain cancer	0.000391	0.00125	CcSEcCtD
Clomifene—Nausea—Hydroxyurea—brain cancer	0.00039	0.00124	CcSEcCtD
Clomifene—KCNH2—brain—brain cancer	0.00039	0.00855	CbGeAlD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000387	0.00271	CbGpPWpGaD
Clomifene—Asthenia—Carmustine—brain cancer	0.000381	0.00121	CcSEcCtD
Clomifene—ABCB1—telencephalon—brain cancer	0.000379	0.00832	CbGeAlD
Clomifene—CYP2E1—central nervous system—brain cancer	0.000378	0.0083	CbGeAlD
Clomifene—Hypersensitivity—Temozolomide—brain cancer	0.000378	0.0012	CcSEcCtD
Clomifene—EBP—Metabolism—CYP2C9—brain cancer	0.000377	0.00265	CbGpPWpGaD
Clomifene—ESR1—FOXM1 transcription factor network—CDKN2A—brain cancer	0.000376	0.00264	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—CDK4—brain cancer	0.000375	0.00263	CbGpPWpGaD
Clomifene—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000375	0.00263	CbGpPWpGaD
Clomifene—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.00037	0.0026	CbGpPWpGaD
Clomifene—CYP2E1—cerebellum—brain cancer	0.000369	0.00811	CbGeAlD
Clomifene—Paraesthesia—Etoposide—brain cancer	0.000368	0.00117	CcSEcCtD
Clomifene—Asthenia—Temozolomide—brain cancer	0.000368	0.00117	CcSEcCtD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000366	0.00257	CbGpPWpGaD
Clomifene—Dyspnoea—Etoposide—brain cancer	0.000366	0.00117	CcSEcCtD
Clomifene—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000364	0.00255	CbGpPWpGaD
Clomifene—Diarrhoea—Carmustine—brain cancer	0.000363	0.00116	CcSEcCtD
Clomifene—Pruritus—Temozolomide—brain cancer	0.000363	0.00116	CcSEcCtD
Clomifene—Fatigue—Etoposide—brain cancer	0.000354	0.00113	CcSEcCtD
Clomifene—Dizziness—Carmustine—brain cancer	0.000351	0.00112	CcSEcCtD
Clomifene—Pain—Etoposide—brain cancer	0.000351	0.00112	CcSEcCtD
Clomifene—Constipation—Etoposide—brain cancer	0.000351	0.00112	CcSEcCtD
Clomifene—Diarrhoea—Temozolomide—brain cancer	0.000351	0.00112	CcSEcCtD
Clomifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000347	0.00244	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—HES1—brain cancer	0.000341	0.00239	CbGpPWpGaD
Clomifene—Dizziness—Temozolomide—brain cancer	0.000339	0.00108	CcSEcCtD
Clomifene—CYP3A4—endocrine gland—brain cancer	0.000337	0.00741	CbGeAlD
Clomifene—Vomiting—Carmustine—brain cancer	0.000337	0.00107	CcSEcCtD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000337	0.00236	CbGpPWpGaD
Clomifene—Rash—Carmustine—brain cancer	0.000334	0.00107	CcSEcCtD
Clomifene—Dermatitis—Carmustine—brain cancer	0.000334	0.00106	CcSEcCtD
Clomifene—Headache—Carmustine—brain cancer	0.000332	0.00106	CcSEcCtD
Clomifene—CYP1A1—brain—brain cancer	0.000329	0.00722	CbGeAlD
Clomifene—CYP11A1—Corticotropin-releasing hormone—RELA—brain cancer	0.000326	0.00229	CbGpPWpGaD
Clomifene—Vomiting—Temozolomide—brain cancer	0.000326	0.00104	CcSEcCtD
Clomifene—Urticaria—Etoposide—brain cancer	0.000326	0.00104	CcSEcCtD
Clomifene—Body temperature increased—Etoposide—brain cancer	0.000324	0.00103	CcSEcCtD
Clomifene—Rash—Temozolomide—brain cancer	0.000323	0.00103	CcSEcCtD
Clomifene—Dermatitis—Temozolomide—brain cancer	0.000323	0.00103	CcSEcCtD
Clomifene—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000323	0.00227	CbGpPWpGaD
Clomifene—Headache—Temozolomide—brain cancer	0.000321	0.00102	CcSEcCtD
Clomifene—EBP—Metabolism—BSG—brain cancer	0.000321	0.00225	CbGpPWpGaD
Clomifene—ESR1—FOXM1 transcription factor network—CCND1—brain cancer	0.000318	0.00223	CbGpPWpGaD
Clomifene—ABCB1—gonad—brain cancer	0.000316	0.00694	CbGeAlD
Clomifene—Nausea—Carmustine—brain cancer	0.000315	0.001	CcSEcCtD
Clomifene—ABCB1—pituitary gland—brain cancer	0.000308	0.00677	CbGeAlD
Clomifene—Nausea—Temozolomide—brain cancer	0.000304	0.00097	CcSEcCtD
Clomifene—CYP3A4—central nervous system—brain cancer	0.000304	0.00668	CbGeAlD
Clomifene—Hypersensitivity—Etoposide—brain cancer	0.000302	0.000963	CcSEcCtD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000301	0.00211	CbGpPWpGaD
Clomifene—CYP2E1—brain—brain cancer	0.0003	0.00659	CbGeAlD
Clomifene—ABCB1—medulla oblongata—brain cancer	0.000298	0.00653	CbGeAlD
Clomifene—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000296	0.00208	CbGpPWpGaD
Clomifene—Asthenia—Etoposide—brain cancer	0.000294	0.000938	CcSEcCtD
Clomifene—CYP11A1—Corticotropin-releasing hormone—IL2—brain cancer	0.000294	0.00206	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000291	0.00204	CbGpPWpGaD
Clomifene—Pruritus—Etoposide—brain cancer	0.00029	0.000925	CcSEcCtD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000285	0.002	CbGpPWpGaD
Clomifene—CYP11A1—Corticotropin-releasing hormone—CTNNB1—brain cancer	0.000283	0.00199	CbGpPWpGaD
Clomifene—Diarrhoea—Etoposide—brain cancer	0.000281	0.000894	CcSEcCtD
Clomifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.00028	0.00196	CbGpPWpGaD
Clomifene—EBP—Metabolism—IDH1—brain cancer	0.000276	0.00194	CbGpPWpGaD
Clomifene—ABCB1—midbrain—brain cancer	0.000272	0.00597	CbGeAlD
Clomifene—Dizziness—Etoposide—brain cancer	0.000271	0.000864	CcSEcCtD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000268	0.00188	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000266	0.00187	CbGpPWpGaD
Clomifene—ABCB1—spinal cord—brain cancer	0.000265	0.00583	CbGeAlD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000261	0.00183	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—VAV1—brain cancer	0.000261	0.00183	CbGpPWpGaD
Clomifene—Vomiting—Etoposide—brain cancer	0.000261	0.000831	CcSEcCtD
Clomifene—Rash—Etoposide—brain cancer	0.000259	0.000824	CcSEcCtD
Clomifene—Dermatitis—Etoposide—brain cancer	0.000258	0.000823	CcSEcCtD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000258	0.00181	CbGpPWpGaD
Clomifene—Headache—Etoposide—brain cancer	0.000257	0.000819	CcSEcCtD
Clomifene—ESR1—FOXM1 transcription factor network—MYC—brain cancer	0.000255	0.00179	CbGpPWpGaD
Clomifene—ESR1—LKB1 signaling events—MYC—brain cancer	0.00025	0.00176	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—CDKN2A—brain cancer	0.00025	0.00176	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000247	0.00173	CbGpPWpGaD
Clomifene—Nausea—Etoposide—brain cancer	0.000244	0.000776	CcSEcCtD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000243	0.0017	CbGpPWpGaD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.000242	0.0017	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—CCND1—brain cancer	0.000242	0.0017	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000241	0.00169	CbGpPWpGaD
Clomifene—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000239	0.00168	CbGpPWpGaD
Clomifene—ABCB1—endocrine gland—brain cancer	0.000239	0.00525	CbGeAlD
Clomifene—ESR1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000238	0.00167	CbGpPWpGaD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000237	0.00166	CbGpPWpGaD
Clomifene—ABCB1—head—brain cancer	0.000236	0.00518	CbGeAlD
Clomifene—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000236	0.00165	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000234	0.00164	CbGpPWpGaD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000232	0.00163	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—RELA—brain cancer	0.000228	0.0016	CbGpPWpGaD
Clomifene—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.000227	0.00159	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—ERBB2—brain cancer	0.000226	0.00159	CbGpPWpGaD
Clomifene—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	0.000226	0.00159	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000225	0.00158	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000223	0.00157	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—IL2—brain cancer	0.000222	0.00156	CbGpPWpGaD
Clomifene—EBP—Metabolism—ENO2—brain cancer	0.000218	0.00153	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—IL2—brain cancer	0.000217	0.00152	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—CCND1—brain cancer	0.000216	0.00152	CbGpPWpGaD
Clomifene—ABCB1—central nervous system—brain cancer	0.000215	0.00473	CbGeAlD
Clomifene—ESR1—Signaling by ERBB4—PDGFRA—brain cancer	0.000214	0.0015	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—CCND1—brain cancer	0.000211	0.00148	CbGpPWpGaD
Clomifene—ABCB1—cerebellum—brain cancer	0.00021	0.00462	CbGeAlD
Clomifene—ESR1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000209	0.00147	CbGpPWpGaD
Clomifene—ESR1—LKB1 signaling events—TP53—brain cancer	0.000205	0.00144	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000201	0.00141	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—CCND1—brain cancer	0.0002	0.0014	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000198	0.00139	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000198	0.00139	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000194	0.00136	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000191	0.00134	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000191	0.00134	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—IRS2—brain cancer	0.000188	0.00132	CbGpPWpGaD
Clomifene—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000184	0.00129	CbGpPWpGaD
Clomifene—ESR1—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.000182	0.00128	CbGpPWpGaD
Clomifene—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000182	0.00128	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000178	0.00125	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000177	0.00125	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000177	0.00124	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—MYC—brain cancer	0.000173	0.00122	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—STAT3—brain cancer	0.000173	0.00121	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000171	0.0012	CbGpPWpGaD
Clomifene—ABCB1—brain—brain cancer	0.000171	0.00375	CbGeAlD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000171	0.0012	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—EGFR—brain cancer	0.00017	0.00119	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.00017	0.00119	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—MYC—brain cancer	0.000169	0.00119	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—CYP2C9—brain cancer	0.000163	0.00115	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000159	0.00112	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000157	0.0011	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000154	0.00108	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000154	0.00108	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000151	0.00106	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000151	0.00106	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000151	0.00106	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000147	0.00103	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000144	0.00101	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000142	0.000998	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—OR14C36—brain cancer	0.000141	0.000989	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—OR4C12—brain cancer	0.000141	0.000989	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—TP53—brain cancer	0.000139	0.000977	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—BSG—brain cancer	0.000139	0.000974	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000138	0.000969	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000132	0.000926	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—ERBB2—brain cancer	0.000129	0.000903	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000128	0.000899	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000128	0.000896	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000127	0.000894	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000126	0.000887	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—DTX2—brain cancer	0.00012	0.000841	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—ESR2—brain cancer	0.00012	0.000839	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—IDH1—brain cancer	0.000119	0.000838	CbGpPWpGaD
Clomifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000119	0.000837	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000114	0.000802	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—NOTCH2—brain cancer	0.000113	0.000795	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000113	0.000794	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000111	0.000781	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000109	0.000764	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CYP2C9—brain cancer	0.000108	0.000759	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000107	0.000752	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000105	0.000739	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000105	0.000734	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—IL2—brain cancer	0.000104	0.000731	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000103	0.00072	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000102	0.000718	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000102	0.000717	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000101	0.000711	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.0001	0.000703	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.0001	0.000703	CbGpPWpGaD
Clomifene—EBP—Metabolism—PIK3CG—brain cancer	0.0001	0.000702	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	9.96e-05	0.000699	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	9.79e-05	0.000688	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	9.79e-05	0.000688	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.71e-05	0.000682	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	9.46e-05	0.000664	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—ENO2—brain cancer	9.43e-05	0.000662	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	9.41e-05	0.000661	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	9.37e-05	0.000658	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—BSG—brain cancer	9.19e-05	0.000645	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.18e-05	0.000644	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—MYC—brain cancer	9.16e-05	0.000643	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PTCH2—brain cancer	9.08e-05	0.000637	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	8.97e-05	0.00063	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—EGFR—brain cancer	8.96e-05	0.000629	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—EGFR—brain cancer	8.91e-05	0.000626	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—VEGFA—brain cancer	8.85e-05	0.000621	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HES5—brain cancer	8.79e-05	0.000617	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CYP2C9—brain cancer	8.6e-05	0.000604	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—STRADA—brain cancer	8.53e-05	0.000599	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	8.4e-05	0.00059	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.25e-05	0.000579	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—IDH1—brain cancer	7.9e-05	0.000555	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	7.75e-05	0.000544	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	7.59e-05	0.000533	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—TP53—brain cancer	7.52e-05	0.000528	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.42e-05	0.000521	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—BSG—brain cancer	7.31e-05	0.000514	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	7.3e-05	0.000512	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ABR—brain cancer	7.12e-05	0.0005	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—GLI2—brain cancer	6.88e-05	0.000483	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYP2C9—brain cancer	6.8e-05	0.000477	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.71e-05	0.000471	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—GLI1—brain cancer	6.47e-05	0.000454	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.43e-05	0.000452	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—DNMT1—brain cancer	6.41e-05	0.00045	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYP2C9—brain cancer	6.41e-05	0.00045	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—IDH1—brain cancer	6.29e-05	0.000442	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—ENO2—brain cancer	6.25e-05	0.000439	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.23e-05	0.000438	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SUFU—brain cancer	6.13e-05	0.00043	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	6.09e-05	0.000428	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—GFAP—brain cancer	5.92e-05	0.000415	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—BSG—brain cancer	5.78e-05	0.000406	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—ESR2—brain cancer	5.75e-05	0.000404	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.67e-05	0.000398	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HEY1—brain cancer	5.61e-05	0.000394	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—DLL1—brain cancer	5.5e-05	0.000386	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—NOTCH2—brain cancer	5.45e-05	0.000383	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—BSG—brain cancer	5.45e-05	0.000383	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP2C9—brain cancer	5.12e-05	0.000359	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.01e-05	0.000352	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ENO2—brain cancer	4.97e-05	0.000349	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—IDH1—brain cancer	4.97e-05	0.000349	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.96e-05	0.000348	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—IDH1—brain cancer	4.69e-05	0.000329	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SHH—brain cancer	4.68e-05	0.000328	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—SIRT1—brain cancer	4.63e-05	0.000325	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TRPC6—brain cancer	4.51e-05	0.000317	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SMO—brain cancer	4.43e-05	0.000311	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PTCH1—brain cancer	4.43e-05	0.000311	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.37e-05	0.000306	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—BSG—brain cancer	4.35e-05	0.000306	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CG—brain cancer	4.33e-05	0.000304	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP2C9—brain cancer	4.09e-05	0.000287	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.02e-05	0.000282	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ENO2—brain cancer	3.93e-05	0.000276	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.93e-05	0.000276	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.82e-05	0.000268	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—MYC—brain cancer	3.77e-05	0.000265	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—IDH1—brain cancer	3.74e-05	0.000263	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ENO2—brain cancer	3.7e-05	0.00026	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NOTCH2—brain cancer	3.54e-05	0.000249	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—BSG—brain cancer	3.47e-05	0.000244	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—VAV1—brain cancer	3.38e-05	0.000237	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.3e-05	0.000232	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYP2C9—brain cancer	3.15e-05	0.000221	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—IDH1—brain cancer	2.99e-05	0.00021	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ENO2—brain cancer	2.96e-05	0.000208	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HES1—brain cancer	2.91e-05	0.000204	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CG—brain cancer	2.87e-05	0.000201	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PDGFRA—brain cancer	2.77e-05	0.000194	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SPP1—brain cancer	2.69e-05	0.000189	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—BSG—brain cancer	2.68e-05	0.000188	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.43e-05	0.000171	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IRS2—brain cancer	2.43e-05	0.000171	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ENO2—brain cancer	2.36e-05	0.000166	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—IDH1—brain cancer	2.31e-05	0.000162	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CG—brain cancer	2.28e-05	0.00016	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CG—brain cancer	2.15e-05	0.000151	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—APC—brain cancer	2.15e-05	0.000151	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ENO2—brain cancer	1.82e-05	0.000128	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—MYC—brain cancer	1.82e-05	0.000127	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CG—brain cancer	1.8e-05	0.000127	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CG—brain cancer	1.7e-05	0.000119	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—RELA—brain cancer	1.68e-05	0.000118	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ERBB2—brain cancer	1.67e-05	0.000117	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IL2—brain cancer	1.51e-05	0.000106	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CCND1—brain cancer	1.47e-05	0.000103	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CTNNB1—brain cancer	1.46e-05	0.000102	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CG—brain cancer	1.36e-05	9.53e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—VEGFA—brain cancer	1.28e-05	9.01e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—STAT3—brain cancer	1.27e-05	8.92e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MYC—brain cancer	1.18e-05	8.29e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EGFR—brain cancer	1.15e-05	8.11e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CG—brain cancer	1.08e-05	7.61e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TP53—brain cancer	9.69e-06	6.81e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CG—brain cancer	8.36e-06	5.87e-05	CbGpPWpGaD
